63 results
Page 2 of 4
8-K
xb7tkoj5yogk8 k4mvu0
3 Feb 21
Other Events
5:25pm
424B5
5ye1ttmew f2bpao
25 Jan 21
Prospectus supplement for primary offering
4:02pm
424B5
bffbu5vk 36mnu
20 Jan 21
Prospectus supplement for primary offering
4:24pm
8-K
EX-99.2
eimdf 47ueu
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
EX-99.1
fafbdo hlfvschirw07
5 Nov 20
Invitae Reports $68.7 Million in Revenue Driven by 170,000 Samples Accessioned in the Third Quarter of 2020
4:24pm
424B3
mht920y igqv0j0w3q
28 Aug 20
Prospectus supplement
4:31pm
425
yro0kcz3mdm662kt
22 Jun 20
Business combination disclosure
5:30pm
8-K
EX-99.4
3czuywi qoki
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.1
8x0v1enc
6 Aug 19
Invitae Reports $53.5 Million in Quarterly Revenue Driven by More Than 111,000 Samples in Quarterly Volume
4:17pm